Henrik Rasmussen
Fondatore presso Renibus Therapeutics, Inc.
Provenienza dei contatti di primo grado di Henrik Rasmussen
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University of Copenhagen
82
| College/University | Other Consumer Services | 82 |
62
| Public Company | Pharmaceuticals: Major | 62 |
| Subsidiary | Pharmaceuticals: Major | 21 | |
11
| Public Company | Pharmaceuticals: Major | 11 |
| Subsidiary | Pharmaceuticals: Major | 9 | |
8
| Subsidiary | Pharmaceuticals: Major | 8 |
Neoprogen, Inc.
 Neoprogen, Inc. BiotechnologyHealth Technology Neoprogen, Inc. engages in the development of cell-based therapy for people who experience a heart attack. The company was founded by Sunjay Kaushal, Rachana Mishra and Sudhish Sharma and is headquartered in Baltimore, MD.
5
| Holding Company | Biotechnology | 5 |
Renibus Therapeutics, Inc.
 Renibus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Renibus Therapeutics, Inc. engages in manufacture of pharmaceutical products. The company was founded by Donald Jeffrey Keyser and Alvaro F. Guillem in 2015 and is headquartered in Southlake, TX.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Nabi Pharmaceuticals
1
| Private Company | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Henrik Rasmussen tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal Sales & Marketing Comptroller/Controller/Auditor Corporate Officer/Principal Sales & Marketing Director of Finance/CFO | |
| Stanford University | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Human Resources Officer Corporate Officer/Principal Corporate Officer/Principal | |
| University of London | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Corporate Officer/Principal Masters Business Admin | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Comptroller/Controller/Auditor Comptroller/Controller/Auditor | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Founder Director/Board Member Private Equity Investor | |
| INTERMUNE INC | Biotechnology | Director/Board Member Corporate Officer/Principal Chief Administrative Officer | |
Copenhagen Infrastructure Partners P/S
 Copenhagen Infrastructure Partners P/S Investment ManagersFinance Copenhagen Infrastructure Partners P/S (CIP) is a private equity firm founded- in 2012 by Jakob Baruël Poulsen, Christian Skakkebæk, Torsten Lodberg Smed, and Rune Bro Róin. The firm is headquartered in Copenhagen, Denmark. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Compliance Officer President | |
| CYTOKINETICS, INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| Michigan State University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree | |
| University of Michigan | College/University | Masters Business Admin Corporate Officer/Principal | |
| IBM | Packaged Software | Public Communications Contact Corporate Officer/Principal | |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Corporate Officer/Principal General Counsel | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chairman Chairman | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Compliance Officer Chief Executive Officer | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Purdue University | College/University | Undergraduate Degree Graduate Degree | |
The Leukemia & Lymphoma Society, Inc.
 The Leukemia & Lymphoma Society, Inc. Miscellaneous Commercial ServicesCommercial Services The Leukemia & Lymphoma Society, Inc. operates as the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. The firm provides treatment for , lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. It identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology and pharmaceutical companies to accelerate the development of new therapies. The company is headquartered in Rye Brook, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| The University of Chicago | College/University | Masters Business Admin Masters Business Admin | |
| Fairleigh Dickinson University | College/University | Graduate Degree Masters Business Admin | |
| ANACOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| Emory University | College/University | Corporate Officer/Principal Doctorate Degree | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Founder General Counsel | |
Pfizer Ltd.
 Pfizer Ltd. Pharmaceuticals: MajorHealth Technology Pfizer Ltd. is a biopharmaceutical company that develops and provides medicines, vaccines, and consumer healthcare products. Its products include prescription and counterfeit medicines, and over-the-counter products. The company was founded in 1952 and is headquartered in Tadworth, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing | |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Roche Innovation Center Copenhagen A/S discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases. The firm manufactures a pipeline of drug candidates that act selectively on disease-related ribonucleic acid to provide patients with novel treatments for both rare and common diseases. It produces pre-clinical and clinical assets for the treatment of a range of diseases including oncology, metabolic diseases, and infectious diseases. The company was founded by Matts Lundwall and Mikael Ørum on January 1, 1998 and is headquartered in Horsholm, Denmark. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| TDC A/S | Major Telecommunications | Corporate Officer/Principal Public Communications Contact | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
The Carlsbergfondet Foundation
 The Carlsbergfondet Foundation Financial ConglomeratesFinance Carlsbergfondet Foundation engages in the financing and promotion of art and art sciences. The company was founded by J. C. Jacobsen in 1876 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
| OMEGA ALPHA SPAC | Financial Conglomerates | Director/Board Member | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 38 |
| Danimarca | 8 |
| Regno Unito | 5 |
| Irlanda | 2 |
| Isole Cayman | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 5 |
| Technology Services | 2 |
Posizioni
| Director/Board Member | 357 |
| Corporate Officer/Principal | 213 |
| Independent Dir/Board Member | 89 |
| Chairman | 82 |
| President | 74 |
Contatti più connessi
| Insiders | |
|---|---|
| Srini Akkaraju Akkaraju | 55 |
| Guy Nohra | 27 |
| Jörgen Axel Thorball | 24 |
| Wendell Wierenga | 23 |
| William N. Kelley | 22 |
| Karen Dawes | 22 |
| Douglas Giordano | 22 |
| Wayne T. Hockmeyer | 22 |
| Marc J. Ostro | 21 |
| Michael Hodges | 20 |
| Kim Popovits | 20 |
| Richard Bagger | 18 |
| Franklin Raines | 18 |
| Frank Stonebanks | 17 |
| Anders Stahlschmidt | 17 |
- Borsa valori
- Insiders
- Henrik Rasmussen
- Connessioni Società
